PVI
FCSC

Pura Vida Investments’s Fibrocell Science Inc. FCSC Stock Holding History

Pura Vida Investments’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-59,400
Closed -$909K – 121
2017
Q3 		$909K Buy
+59,400
New +$960K 0.16% 78

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Pura Vida Investments's FCSC Position: Q4 2017 in Review

Pura Vida Investments sold out of Fibrocell Science Inc. (FCSC) in Q4 2017, closing a stake of 59,400 shares — an estimated $909K sold.

Pura Vida Investments first reported a position in FCSC in Q3 2017 and held it in 1 quarter. The position peaked at $909K in Q3 2017. 32 funds tracked by Wall St. Rank hold FCSC as of Q4 2017.

  • Pura Vida Investments reported no remaining Fibrocell Science Inc. position as of Q4 2017 after selling out during the quarter.
  • Pura Vida Investments sold 59,400 Fibrocell Science Inc. shares in Q4 2017, an estimated $909K.
  • Pura Vida Investments first reported a position in Fibrocell Science Inc. in Q3 2017 and held it in 1 quarter.
  • Pura Vida Investments's Fibrocell Science Inc. position peaked at $909K in Q3 2017.
  • 32 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2017.

Based on Pura Vida Investments's 13F filing for Q4 2017, filed 14 Feb 2018.